Skip to main content

and
  1. No Access

    Article

    Integrating pharmacogenetics into gemcitabine dosing—time for a change?

    A number of biomarkers that predict clinical outcome in response to gemcitabine treatment have been identified. These markers could be used in the clinic to personalize treatment, thereby improving efficacy an...

    Joseph Ciccolini, Cédric Mercier, Laetitia Dahan in Nature Reviews Clinical Oncology (2011)